Avacta Group PLC (AVCT)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

76.00p

Buy

78.00p

arrow-up0.10p (+0.13%)

Prices updated at 12 Dec 2025, 17:07 GMT

Prices minimum 15 mins delay

Prices in GBX

Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Biotechnology

Chairman

Mr. Shaun Edward Chilton

CEO

Dr. Christina Marie Coughlin

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

151

Head office

58 Wood Lane

London

United Kingdom

W12 7RZ

+44 2039110353

investors@avacta.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Shaun Edward Chilton Non-Executive Director, Chairman	-
Ms. Darlene Marie Deptula-Hicks Non-Executive Director	-
Mr. Paul Andrew Fry Non-Executive Director	-
Dr. Christina Marie Coughlin Executive Director, Chief Executive Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Unicorn Asset Management Ltd	4,300,000
Unicorn AIM VCT Series 3 ORD	4,300,000
AXA Investment Managers UK Ltd	3,228,954
UTM IM GBP AXA Framlington Biotech	3,228,954
FIL Life Insurance Limited	2,379,070

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.